Analyst	Recommendation	Action	Price target	Projected	Date
Biren Amin Piper Sandler	Buy	Maintained	$140.00	+14.7%	09/23/2026
Alex Thompson CFA Stifel Nicolaus	Buy	Maintained	$152.00	+24.5%	09/22/2026
Tazeen Ahmad Bank of America Securities	Buy	Reiterated	$144.00	+18%	09/14/2026
Andy Chen Wolfe Research	Buy	Upgraded	$180.00	+47.5%	09/10/2026
Brian Cheng J.P. Morgan	Buy	Maintained	$140.00	+14.7%	09/03/2026
Brian Abrahams RBC Capital	Hold	Maintained	$112.00	-8.2%	09/02/2026
Bradley Canino Guggenheim	Buy	Reiterated	$170.00	+39.3%	08/30/2026
Derek Archila Wells Fargo	Buy	Reiterated	$151.00	+23.7%	08/27/2026
Judah Frommer Morgan Stanley	Buy	Reiterated	$135.00	+10.6%	08/06/2026
Edward Nash Canaccord Genuity	Buy	Reiterated	$129.00	+5.7%	08/06/2026
David Dai UBS	Buy	Maintained	$128.00	+4.9%	08/05/2026
Andrew Fein H.C. Wainwright	Buy	Maintained	$134.00	+9.8%	08/06/2026
Geoff Meacham Citi	Buy	Maintained	$135.00	+10.6%	08/06/2026
Eliana Merle Barclays	Buy	Maintained	$139.00	+13.9%	08/06/2026
David Hoang Deutsche Bank	Hold	Initiated	$120.00	-1.7%	07/29/2026
Joseph Catanzaro Mizuho Securities	Buy	Maintained	$140.00	+14.7%	07/16/2026
Daniel Giraldo Bank of America Securities	Buy	Reiterated	$125.00	+2.4%	06/29/2026
Srikripa Devarakonda Truist Financial	Buy	Reiterated	$136.00	+11.4%	06/29/2026
Mayank Mamtani B. Riley Securities	Buy	Reiterated	$155.00	+27%	06/29/2026
Unknown Analyst B. Riley Securities	Buy	Maintained	$155.00	+27%	06/26/2026
Unknown Analyst Wells Fargo	Buy	Reiterated	$116.00	-5%	06/26/2026
Jeet Mukherjee BTIG	Buy	Maintained	$134.00	+9.8%	06/25/2026
Marc Frahm TD Cowen	Buy	Maintained	-	-	05/05/2026
Kelly Shi Jefferies	Buy	Initiated	$110.00	-9.9%	03/15/2026
Faisal Khurshid Jefferies	Buy	Initiated	$110.00	-9.9%	03/15/2026
Sudan Loganathan Stephens	Buy	Maintained	$100.00	-18.1%	03/02/2026
Jeff Jones Oppenheimer	Buy	Reiterated	$120.00	-1.7%	02/27/2026

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	2.76M	2.87M	34.36M	65.00M
Cost of goods sold	74.09M	83.83M	98.16M	119.48M
Cost of revenue	74.09M	83.83M	98.16M	119.48M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	17.34M	16.94M	20.36M	21.13M
Operating expense	17.34M	16.94M	20.36M	21.13M
Total operating expenses	91.43M	100.77M	118.52M	140.61M
Operating income	-88.67M	-97.90M	-84.15M	-75.61M
Other non operating income	-	-	5.00K	-25.00K
EBT including unusual items	-82.18M	-86.98M	-69.23M	-61.21M
EBT excluding unusual items	-78.32M	-86.98M	-69.23M	-61.21M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-82.18M	-86.98M	-69.23M	-61.21M
Net profit margin	-2,973.05%	-3,030.70%	-201.47%	-94.17%
Earnings per share	-0.94	-0.98	-0.71	-0.62
Interest and investment income	10.44M	11.00M	14.98M	14.48M
Interest expense	-98.00K	-90.00K	-66.00K	-56.00K
Net interest expenses	10.35M	10.92M	14.92M	14.42M
Depreciation and amortization charges	-	-	-	-
EBITDA	-85.82M	-97.46M	-82.13M	-74.48M
Gain or loss from assets sale	-	-	-	-

Ask anything